Akso Health (AHG) Common Equity (2017 - 2026)

Akso Health (AHG) has reported Common Equity for 10 consecutive years, with $180.9 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 9.15% year-over-year to $180.9 million; the trailing twelve-month figure through Mar 2026 stood at $180.9 million (down 9.15% YoY), and the FY2026 full-year result was $180.9 million, down 9.15% from the prior year.
• Common Equity slipped to $180.9 million in Q1 2026 per AHG's latest filing, from $198.3 million in the prior quarter.
• Across five years, Common Equity topped out at $200.7 million in Q3 2024 and bottomed at $5.3 million in Q3 2023.
• Historically, Common Equity has averaged $106.0 million across 5 years, with a median of $138.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Common Equity tumbled 49.21% in 2022, then jumped 3663.53% in 2024.
• Over 5 years, Common Equity stood at $9.9 million in 2022, then slumped by 46.31% to $5.3 million in 2023, then surged by 3663.53% to $200.7 million in 2024, then retreated by 1.17% to $198.3 million in 2025, then retreated by 8.77% to $180.9 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $180.9 million, $198.3 million, and $199.2 million for Q1 2026, Q3 2025, and Q1 2025 respectively.